Cancer Biomarker Discovery and Assay Development
Conference - London, United Kingdom
Whilst numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers are already being used at some point in patient care. This event will discuss the further discovery and assay development of genetic, epigenetic, proteomic, glycomic, and imaging biomarkers which can be used for cancer diagnosis, prognosis, and epidemiology. We provide an informal atmosphere for discussion and debate. This is an ideal setting for experts to present their work and discuss their findings.
Organization: Euroscicon
(Courtesy of PeptiQuant™ Human Cancer MRM Assay, via mrmproteomics.com)
Tue, May 13, 2014 - Tue, May 13, 2014
Cineworld: The O2
Peninsula Square, London
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.